IDC’s Conway Sets Stage for SC16 Precision Medicine Panel

By John Russell

November 4, 2016

Editor’s Note: Kicking off SC this year is what promises to be a fascinating panel – HPC Impacts on Precision Medicine: Life’s Future–The Next Frontier in Healthcare. In this pre-SC16 Q&A, Steve Conway, research vice president in IDC’s High Performance Computing group and moderator of the panel, sets the stage. HPC, of course, has been transforming life sciences and medicine for nearly two decades. The transformation began in research – sequencing the Human Genome was as much an HPC achievement as it was a triumph of new DNA sequencing instruments. HPC has since moved steadily albeit slowly into the clinic. There are even special purpose supercomputers – Anton – dedicated to life sciences.

What’s emerged is this umbrella notion of precision medicine (PM), the idea that it should be possible to leverage all of our hard-won knowledge, new instrument technology, computational power, and a growing wealth of data spanning individuals to populations to deliver more effective therapies, preventative measures, and even lifestyle enhancing choices. That’s a mouthful. Genomics is the most prominently touted enabler but there are many pieces to the PM puzzle.

We are still at the edge of this sea. Only in recent years, for example, have we come to appreciate the influence the microbiome in each of us has on health. Yet while so much remains to be discovered much has been accomplished. Precision medicine is already starting to transform healthcare; in certain cancers, for example, it has proven decisive. Expectations are high. Think of the many recent and ongoing initiatives such as the Brain Initiative, the Cancer Moonshot, the 1000 Genomes project, the Blue Brain Project, and Human Microbiome Project, to name just a few, all of which depend upon advanced computing. It seems fitting for SC to showcase the importance HPC plays in life sciences research and medicine. – John Russell

HPCwire: The fact that Precision Medicine is the opening panel at SC strongly suggests the growing importance of HPC in making PM and basic life science research possible. Recognizing SC is primarily a technology conference, could you frame the goals of this panel?

Steve Conway: Precision medicine, also called personalized medicine, promises to transform medical practice and healthcare spending by enabling called personalized diagnoses and treatment plans that are custom-tuned for each patient’s physiology, symptoms, medical history, DNA and even lifestyle. What constitutes a good outcome for a broken hand may be different for an office worker and a concert violinist. HPC is already playing a key role in early precision medicine initiatives around the world, by speeding up genome sequencing and by making it possible to quickly sift through millions of archived patient records to identify treatments that have had the best success rates for patients closely resembling the patient under investigation. Biology is fast becoming a digital science and healthcare analytics is one of the fastest-growing new market segments for HPC. Precision medicine is happening at the intersection of biology, medical practice, healthcare economics, and data science. The expert panel at SC’16 will explore this emerging domain from these varied perspectives, with special emphasis on the major role HPC has already started to play.

Warren Kibbe, NCI
Warren Kibbe, NCI

This is a pretty august group:

  • Mitchell Cohen, Director of Surgery, Denver Health Medical Center; Professor, University of Colorado School of Medicine.
  • Martha Head, Senior Director, The Noldor; Acting Head, Insights from Data at GlaxoSmithKline Pharmaceuticals
  • Warren Kibbe, Director, Center for Biomedical Informatics and Information Technology (CBIIT); Chief Information Officer; Acting Deputy Director; National Cancer Institute (NCI)
  • Dimitri Kusnezov, Chief Scientist & Senior Advisor to the Secretary, U.S. Department of Energy, National Nuclear Security Administration
  • Steve Scott, Chief Technology Officer, Cray Inc.

HPCwire: Today much what constitutes PM is big data analytics. Within this context: a) what are the key technologies (compute/architectures, storage, informatics, etc) being used, b) what are the big technology challenges/bottlenecks, and c) where do you expect near-term progress?

Conway: We’ll hear more about this from the experts on the panel, but in general the computer technologies being used today to support precision medicine vary from purpose-built supercomputers such as IBM Watson with its advanced natural language capability to Linux clusters with the usual processors and software. One big challenge is getting access to detailed data on large enough patient populations—some big healthcare companies are investing a lot of money today to acquire more data. Another challenge is speed. An important decision-support goal over time is for the computer to spit out efficacy curves for treatment options in near-real time, while the patient is still sitting across from the doctor. Yet another challenge is the state of the data science—there’s a big need for tools that help users understand the data better, including benchmarks to verify that the results are useful.

HPCwire: How significant is the relative lack of HPC expertise and general computational literacy of most clinical physicians and even life scientists generally? The command line is hardly a friendly place for them. What, if anything, should be done to support them and to raise their computational skill level?

Conway: One of the biggest barriers across all of HPC is the C. P. Snow “two cultures” problem, where in the case of HPC you have computer scientists and domain scientists trying to communicate with each other using different languages. In precision medicine you might have HPC vendors talking about integer or floating point operations per second, while the buyers and users want to hear about cancer detections per second. My own opinion is that in precision medicine, to be successful HPC vendors will need to bend more toward the users than the other way around. I don’t think vendors can expect users to make a big effort to become more proficient in HPC. It will be interesting to hear what the panelists at SC’16 have to say about this.

watson.jpgHPCwire: How should we expect delivery of PM technology to evolve? IBM Watson has received a lot of attention using a cloud-like model while many institutions have on-premise resources. How will the PM delivery ecosystem (HPC infrastructure) evolve?

Conway: Again, you’ll get a fuller discussion of this during the SC panel session, but it seems clear that an effective precision medicine environment will involve both on-premise and cloud resources, presumably integrated in a way that’s transparent to users. You’ll need on-premise resources for brute force computing and cloud resources for things including data research, records transfer and general communication. Most healthcare systems already rely on private clouds for communication among providers and between providers and patients. The brute force computing will be needed for near-real time diagnosis and treatment planning.

HPCwire: What are the two or three examples of the most advanced HPC-based PM systems used today and what makes them distinct?

Conway: Let’s start with IBM Watson. In 2011, Watson stunned a huge American television audience by defeating two human past champions of the Jeopardy! game show in a competition match. The great achievement of this digital brain was its ability to “understand” natural language — specifically, natural language expressed in the interrogatory syntax of the game show. On the heels of this triumph, IBM announced in January 2014 that it would invest $1 billion to advance Watson’s decision-making abilities for major commercial markets, including healthcare. Not much later, in May 2015, IBM said 14 U.S. cancer treatment centers had signed on to receive personalized treatment plans selected by a Watson supercomputer. Watson has contracted since Jeopardy! days “from the size of a master bedroom to three stacked pizza boxes.” Watson will parse the DNA of each patient’s cancer and recommend what it considers the optimal medical treatment, so it’s a powerful decision-support tool for healthcare providers.

The Center for Pediatric Genomic Medicine at Children’s Mercy Hospital, Kansas City, Missouri, has been using supercomputer power to help save the lives of critically ill children. In 2010, the center’s work was named one of Time magazine’s top 10 medical breakthroughs. Roughly 4,100 genetic diseases affect humans, and these are the main causes of infant deaths. But identifying which genetic disease is affecting a critically ill child isn’t easy. For one infant suffering from liver failure, the center used 25 hours of supercomputer time to analyze 120 billion nucleotide sequences and narrowed the problem down to two genetic variants. This allowed the doctors to begin treatment with corticosteroids and immunoglobulin. Thanks to this highly accurate diagnosis of the problem and pinpointed treatment, the baby is alive and well today. For 48% of the cases the center works on today, supercomputer-powered genetic diagnosis points the way toward a more effective treatment.

genomics.jpgThe University of Toronto’s SickKids Centre for Computational Medicine uses a supercomputer operating at 107 trillion calculations per second to predict the minute differences between individual children in order to identify the best treatment for each child under their care.

Researchers at the University of Oslo (Norway) are using a supercomputer to help identify the genes that cause bowel and prostate cancer, two common forms of the disease. There are 4,000 new cases of bowel cancer in Norway every year. Only 6 out of 10 patients survive the first five years. Prostate cancer affects 5,000 Norwegians every year and 9 out of 10 patients survive. The researchers are employing the supercomputer to compare the genetic makeup of healthy cells and cancer cells, paying special attention to complex genes called fusion genes.

The Frédéric Joliot Hospital Department (Orsay, France) is using the powerful supercomputer at the French Alternative Energies and Atomic Energy Commission (CEA) in Bruyères-le-Châtel to improve understanding of how tracers used in PET scans for cancer diagnosis distribute themselves through the body. The goals of this research are to optimize PET scan data analysis and, later on, to personalize the PET scan process for each patient in order to produce better outcomes.

Doctors at Australia’s Victor Chang Cardiac Research Institute are using supercomputer-based gaming technology to identify how individuals’ genetic makeups can affect the severity of their heart rhythm diseases. The researchers built a virtual heart, then applied the recorded heartbeats of patients to the digital heart model in order to spot abnormal electrocardiogram signals. The whole process took 10 days using HPC, instead of the 21 years it would have taken with a contemporary personal computer. In other words, this important work would be impractical without the supercomputer.

HPCwire: To a large degree, mechanistic modeling and simulation – beyond compound structure analysis and docking scoring – hasn’t played a large role in the clinic or basic research. Do you think this will change and what will drive the change?

Anton 1 supercomputer specialized for life sciences modeling and simulation
Anton 1 supercomputer specialized for life sciences modeling and simulation

Conway: Modeling and simulation will continue to play a key role in designing a wide array of medical technology products used in clinical practice, from heart pacemakers to diagnostic imaging tools such as MRI and PET scanners. M&S is also crucial for genome sequencing and precision dosing of pharmaceuticals, both of which are important for precision medicine. I think M&S and advanced analytics will go hand-in-hand in this emerging market.

HPCwire: What haven’t I asked that I should?

Conway: Just that precision medicine will be the next market segment IDC adds to the ones we track in our high performance data analysis, or HPDA, practice. Precision medicine will join fraud and anomaly detection, affinity marketing and business intelligence as new segments that are made up mainly of large commercial firms that have adopted HPC for the first time. We forecast that the whole HPDA server and storage market will exceed $5 billion in 2020. Of that amount, about $3.5 billion will come from existing HPC sites and about $1.6 billion will be added to the HPC market by new commercial buyers. Assuming that precision medicine fulfills its promise over the next decade, it is likely to become the single largest market for HPDA, that is, data-intensive computing using HPC resources.

 

steve-conway-idcSteve Conway, is research vice president in IDC’s High Performance Computing group where he plays a major role in directing and implementing HPC research related to the worldwide market for technical servers and supercomputers. He is a 25-year veteran of the HPC and IT industries. Before joining IDC, Conway was vice president of corporate communications and investor relations for Cray, and before that had stints at SGI and CompuServe Corporation.

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

Help Wanted: QED-C Survey Spotlights Skills Sought by Quantum Industry

September 28, 2021

Developing an adequate workforce for the young but fast-growing quantum information sciences industry is seen as a critical element for success. Just what that means in terms of skillsets and positions is becoming cleare Read more…

Pittsburgh Supercomputer Powers Machine Learning Analysis of Rare East Asian Stamps

September 27, 2021

Setting aside the relatively recent rise of electronic signatures, personalized stamps have been a popular form of identification for formal documents in East Asia. These identifiers – easily forged, but culturally ubi Read more…

Purdue Researchers Peer into the ‘Fog of the Machine Learning Accelerator War’

September 27, 2021

Making sense of ML performance and benchmark data is an ongoing challenge. In light of last week’s release of the most recent MLPerf (v1.1) inference results, now is perhaps a good time to review how valuable (or not) Read more…

Quantum Monte Carlo at Exascale Could Be Key to Finding New Semiconductor Materials

September 27, 2021

Researchers are urgently trying to identify possible materials to replace silicon-based semiconductors. The processing power in modern computers continues to increase even as the size of the silicon on which components a Read more…

The Case for an Edge-Driven Future for Supercomputing

September 24, 2021

“Exascale only becomes valuable when it’s creating and using data that we care about,” said Pete Beckman, co-director of the Northwestern-Argonne Institute of Science and Engineering (NAISE), at the most recent HPC Read more…

AWS Solution Channel

Introducing AWS ParallelCluster 3

Running HPC workloads, like computational fluid dynamics (CFD), molecular dynamics, or weather forecasting typically involves a lot of moving parts. You need a hundreds or thousands of compute cores, a job scheduler for keeping them fed, a shared file system that’s tuned for throughput or IOPS (or both), loads of libraries, a fast network, and a head node to make sense of all this. Read more…

Three Universities Team for NSF-Funded ‘ACES’ Reconfigurable Supercomputer Prototype

September 23, 2021

As Moore’s law slows, HPC developers are increasingly looking for speed gains in specialized code and specialized hardware – but this specialization, in turn, can make testing and deploying code trickier than ever. Now, researchers from Texas A&M University, the University of Illinois at Urbana... Read more…

Purdue Researchers Peer into the ‘Fog of the Machine Learning Accelerator War’

September 27, 2021

Making sense of ML performance and benchmark data is an ongoing challenge. In light of last week’s release of the most recent MLPerf (v1.1) inference results, Read more…

Quantum Monte Carlo at Exascale Could Be Key to Finding New Semiconductor Materials

September 27, 2021

Researchers are urgently trying to identify possible materials to replace silicon-based semiconductors. The processing power in modern computers continues to in Read more…

The Case for an Edge-Driven Future for Supercomputing

September 24, 2021

“Exascale only becomes valuable when it’s creating and using data that we care about,” said Pete Beckman, co-director of the Northwestern-Argonne Institut Read more…

Three Universities Team for NSF-Funded ‘ACES’ Reconfigurable Supercomputer Prototype

September 23, 2021

As Moore’s law slows, HPC developers are increasingly looking for speed gains in specialized code and specialized hardware – but this specialization, in turn, can make testing and deploying code trickier than ever. Now, researchers from Texas A&M University, the University of Illinois at Urbana... Read more…

Qubit Stream: Monte Carlo Advance, Infosys Joins the Fray, D-Wave Meeting Plans, and More

September 23, 2021

It seems the stream of quantum computing reports never ceases. This week – IonQ and Goldman Sachs tackle Monte Carlo on quantum hardware, Cambridge Quantum pu Read more…

Asetek Announces It Is Exiting HPC to Protect Future Profitability

September 22, 2021

Liquid cooling specialist Asetek, well-known in HPC circles for its direct-to-chip cooling technology that is inside some of the fastest supercomputers in the world, announced today that it is exiting the HPC space amid multiple supply chain issues related to the pandemic. Although pandemic supply chain... Read more…

TACC Supercomputer Delves Into Protein Interactions

September 22, 2021

Adenosine triphosphate (ATP) is a compound used to funnel energy from mitochondria to other parts of the cell, enabling energy-driven functions like muscle contractions. For ATP to flow, though, the interaction between the hexokinase-II (HKII) enzyme and the proteins found in a specific channel on the mitochondria’s outer membrane. Now, simulations conducted on supercomputers at the Texas Advanced Computing Center (TACC) have simulated... Read more…

The Latest MLPerf Inference Results: Nvidia GPUs Hold Sway but Here Come CPUs and Intel

September 22, 2021

The latest round of MLPerf inference benchmark (v 1.1) results was released today and Nvidia again dominated, sweeping the top spots in the closed (apples-to-ap Read more…

Ahead of ‘Dojo,’ Tesla Reveals Its Massive Precursor Supercomputer

June 22, 2021

In spring 2019, Tesla made cryptic reference to a project called Dojo, a “super-powerful training computer” for video data processing. Then, in summer 2020, Tesla CEO Elon Musk tweeted: “Tesla is developing a [neural network] training computer called Dojo to process truly vast amounts of video data. It’s a beast! … A truly useful exaflop at de facto FP32.” Read more…

Enter Dojo: Tesla Reveals Design for Modular Supercomputer & D1 Chip

August 20, 2021

Two months ago, Tesla revealed a massive GPU cluster that it said was “roughly the number five supercomputer in the world,” and which was just a precursor to Tesla’s real supercomputing moonshot: the long-rumored, little-detailed Dojo system. “We’ve been scaling our neural network training compute dramatically over the last few years,” said Milan Kovac, Tesla’s director of autopilot engineering. Read more…

Esperanto, Silicon in Hand, Champions the Efficiency of Its 1,092-Core RISC-V Chip

August 27, 2021

Esperanto Technologies made waves last December when it announced ET-SoC-1, a new RISC-V-based chip aimed at machine learning that packed nearly 1,100 cores onto a package small enough to fit six times over on a single PCIe card. Now, Esperanto is back, silicon in-hand and taking aim... Read more…

CentOS Replacement Rocky Linux Is Now in GA and Under Independent Control

June 21, 2021

The Rocky Enterprise Software Foundation (RESF) is announcing the general availability of Rocky Linux, release 8.4, designed as a drop-in replacement for the soon-to-be discontinued CentOS. The GA release is launching six-and-a-half months after Red Hat deprecated its support for the widely popular, free CentOS server operating system. The Rocky Linux development effort... Read more…

Intel Completes LLVM Adoption; Will End Updates to Classic C/C++ Compilers in Future

August 10, 2021

Intel reported in a blog this week that its adoption of the open source LLVM architecture for Intel’s C/C++ compiler is complete. The transition is part of In Read more…

Hot Chips: Here Come the DPUs and IPUs from Arm, Nvidia and Intel

August 25, 2021

The emergence of data processing units (DPU) and infrastructure processing units (IPU) as potentially important pieces in cloud and datacenter architectures was Read more…

AMD-Xilinx Deal Gains UK, EU Approvals — China’s Decision Still Pending

July 1, 2021

AMD’s planned acquisition of FPGA maker Xilinx is now in the hands of Chinese regulators after needed antitrust approvals for the $35 billion deal were receiv Read more…

Google Launches TPU v4 AI Chips

May 20, 2021

Google CEO Sundar Pichai spoke for only one minute and 42 seconds about the company’s latest TPU v4 Tensor Processing Units during his keynote at the Google I Read more…

Leading Solution Providers

Contributors

HPE Wins $2B GreenLake HPC-as-a-Service Deal with NSA

September 1, 2021

In the heated, oft-contentious, government IT space, HPE has won a massive $2 billion contract to provide HPC and AI services to the United States’ National Security Agency (NSA). Following on the heels of the now-canceled $10 billion JEDI contract (reissued as JWCC) and a $10 billion... Read more…

10nm, 7nm, 5nm…. Should the Chip Nanometer Metric Be Replaced?

June 1, 2020

The biggest cool factor in server chips is the nanometer. AMD beating Intel to a CPU built on a 7nm process node* – with 5nm and 3nm on the way – has been i Read more…

Julia Update: Adoption Keeps Climbing; Is It a Python Challenger?

January 13, 2021

The rapid adoption of Julia, the open source, high level programing language with roots at MIT, shows no sign of slowing according to data from Julialang.org. I Read more…

Quantum Roundup: IBM, Rigetti, Phasecraft, Oxford QC, China, and More

July 13, 2021

IBM yesterday announced a proof for a quantum ML algorithm. A week ago, it unveiled a new topology for its quantum processors. Last Friday, the Technical Univer Read more…

Frontier to Meet 20MW Exascale Power Target Set by DARPA in 2008

July 14, 2021

After more than a decade of planning, the United States’ first exascale computer, Frontier, is set to arrive at Oak Ridge National Laboratory (ORNL) later this year. Crossing this “1,000x” horizon required overcoming four major challenges: power demand, reliability, extreme parallelism and data movement. Read more…

Intel Launches 10nm ‘Ice Lake’ Datacenter CPU with Up to 40 Cores

April 6, 2021

The wait is over. Today Intel officially launched its 10nm datacenter CPU, the third-generation Intel Xeon Scalable processor, codenamed Ice Lake. With up to 40 Read more…

Intel Unveils New Node Names; Sapphire Rapids Is Now an ‘Intel 7’ CPU

July 27, 2021

What's a preeminent chip company to do when its process node technology lags the competition by (roughly) one generation, but outmoded naming conventions make it seem like it's two nodes behind? For Intel, the response was to change how it refers to its nodes with the aim of better reflecting its positioning within the leadership semiconductor manufacturing space. Intel revealed its new node nomenclature, and... Read more…

The Latest MLPerf Inference Results: Nvidia GPUs Hold Sway but Here Come CPUs and Intel

September 22, 2021

The latest round of MLPerf inference benchmark (v 1.1) results was released today and Nvidia again dominated, sweeping the top spots in the closed (apples-to-ap Read more…

  • arrow
  • Click Here for More Headlines
  • arrow
HPCwire